Senior Cannabis Consumers Drive CBD Demand in Colorado Market Study
New research reveals 60+ first-time buyers favor CBD-THC combinations over pure THC products, signaling market shift toward wellness-focused consumption patterns.
Colorado's senior cannabis market demonstrates a clear preference for CBD-dominant products, with first-time buyers aged 60 and older choosing combination CBD-THC formulations at nearly three times the rate of THC-only options. The University of Utah study tracking 169 participants found 57.5% selected balanced cannabinoid products, highlighting a demographic shift that could reshape product development strategies across the industry.
This consumption pattern reflects broader market trends favoring wellness-oriented cannabis products over traditional recreational formats. Senior consumers typically seek therapeutic benefits for pain management, sleep disorders, and anxiety relief rather than psychoactive effects, driving demand for products with higher CBD ratios that deliver medical benefits without intense intoxication.
The findings carry revenue implications for multi-state operators and product manufacturers focusing on medical cannabis segments. Companies like Curaleaf Holdings (CURLF) and Green Thumb Industries (GTBIF) have expanded CBD-focused product lines targeting older demographics, recognizing this population's growing purchasing power and willingness to pay premium prices for quality formulations.
Colorado's mature cannabis market serves as a bellwether for consumption trends that typically spread to newer recreational states. As more jurisdictions legalize adult-use cannabis, operators can leverage this demographic data to optimize product portfolios and inventory allocation. The preference for balanced cannabinoid profiles suggests opportunities for brands emphasizing precise dosing, consistent effects, and medical-grade quality standards.
The senior market represents untapped growth potential as baby boomers increasingly embrace cannabis alternatives to traditional pharmaceuticals. This demographic shift toward CBD-dominant products validates investment in extraction technologies, minor cannabinoid research, and targeted marketing strategies that position cannabis as a mainstream wellness category rather than purely recreational consumption.